495 related articles for article (PubMed ID: 16471901)
21. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
22. CD4 mimics targeting the mechanism of HIV entry.
Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
[TBL] [Abstract][Full Text] [Related]
23. Effect of polyanion-resistance on HIV-1 infection.
Bobardt MD; Armand-Ugón M; Clotet I; Zhang Z; David G; Este JA; Gallay PA
Virology; 2004 Aug; 325(2):389-98. PubMed ID: 15246277
[TBL] [Abstract][Full Text] [Related]
24. Molecular dynamics study of the proposed beta-hairpin form of the switch domain from HIV1 gp120 alone and complexed with an inhibitor of CD4 binding.
Graf von Stosch A; von der Lieth CW; Reed J
Proteins; 1999 Feb; 34(2):197-205. PubMed ID: 10022355
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group.
Lu RJ; Tucker JA; Zinevitch T; Kirichenko O; Konoplev V; Kuznetsova S; Sviridov S; Pickens J; Tandel S; Brahmachary E; Yang Y; Wang J; Freel S; Fisher S; Sullivan A; Zhou J; Stanfield-Oakley S; Greenberg M; Bolognesi D; Bray B; Koszalka B; Jeffs P; Khasanov A; Ma YA; Jeffries C; Liu C; Proskurina T; Zhu T; Chucholowski A; Li R; Sexton C
J Med Chem; 2007 Dec; 50(26):6535-44. PubMed ID: 18052117
[TBL] [Abstract][Full Text] [Related]
26. Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development.
Kadow J; Wang HG; Lin PF
Curr Opin Investig Drugs; 2006 Aug; 7(8):721-6. PubMed ID: 16955683
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
Boussard C; Klimkait T; Mahmood N; Pritchard M; Gilbert IH
Bioorg Med Chem Lett; 2004 May; 14(10):2673-6. PubMed ID: 15109676
[TBL] [Abstract][Full Text] [Related]
28. Specific CD4 down-modulating compounds with potent anti-HIV activity.
Vermeire K; Schols D
J Leukoc Biol; 2003 Nov; 74(5):667-75. PubMed ID: 12960237
[TBL] [Abstract][Full Text] [Related]
29. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
[TBL] [Abstract][Full Text] [Related]
30. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation.
Ishii T; Mori T; Tanaka T; Mizuno D; Yamaji R; Kumazawa S; Nakayama T; Akagawa M
Free Radic Biol Med; 2008 Nov; 45(10):1384-94. PubMed ID: 18771724
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory modulation of ATP-sensitive potassium channels by gallate-ester moiety of (-)-epigallocatechin-3-gallate.
Baek WK; Jang BC; Lim JH; Kwon TK; Lee HY; Cho CH; Kim DK; Shin DH; Park JG; Lim JG; Bae JH; Bae JH; Yoo SK; Park WK; Song DK
Biochem Pharmacol; 2005 Nov; 70(11):1560-7. PubMed ID: 16216226
[TBL] [Abstract][Full Text] [Related]
32. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols.
Landis-Piwowar KR; Wan SB; Wiegand RA; Kuhn DJ; Chan TH; Dou QP
J Cell Physiol; 2007 Oct; 213(1):252-60. PubMed ID: 17477351
[TBL] [Abstract][Full Text] [Related]
33. Molecular docking guided structure based design of symmetrical N,N'-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors.
Sivan SK; Vangala R; Manga V
Bioorg Med Chem; 2013 Aug; 21(15):4591-9. PubMed ID: 23777826
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for the interaction between focal adhesion kinase and CD4.
Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
[TBL] [Abstract][Full Text] [Related]
35. CD4 binding partially locks the bridging sheet in gp120 but leaves the beta2/3 strands flexible.
Pan Y; Ma B; Nussinov R
J Mol Biol; 2005 Jul; 350(3):514-27. PubMed ID: 15946678
[TBL] [Abstract][Full Text] [Related]
36. Identification of putative, stable binding regions through flexibility analysis of HIV-1 gp120.
Tan H; Rader AJ
Proteins; 2009 Mar; 74(4):881-94. PubMed ID: 18704932
[TBL] [Abstract][Full Text] [Related]
37. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis.
Sharma SK; Kumar G; Kapoor M; Surolia A
Biochem Biophys Res Commun; 2008 Mar; 368(1):12-7. PubMed ID: 17996734
[TBL] [Abstract][Full Text] [Related]
38. Understanding of the bridging sheet formation of HIV-1 glycoprotein gp120.
Da LT; Quan JM; Wu YD
J Phys Chem B; 2009 Oct; 113(43):14536-43. PubMed ID: 19813706
[TBL] [Abstract][Full Text] [Related]
39. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability.
Wang Y; Zhang H; Holmgren A; Tian W; Zhong L
Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
